Page 28 - Read Online
P. 28
In the present study, both patients were treated at Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP,
recurrence with carmustine wafers that were placed Weaver SA, Green RM, Kamar FG, Abrey LE, DeAngelis LM,
around the resection cavity. Carmustine wafers have Jhanwar SC, Rosenblum MK, Lassman AB. Recursive partitioning
analysis of prognostic variables in newly diagnosed anaplastic
been shown to yield better survival rates of 1-2 months oligodendroglial tumors. Neuro Oncol 2014;16:1541‑6.
in primary high-grade gliomas. [16] Thus, the prolonged 7. Miller JT, Rahimi SY, Lee M. History of infection control and its
survival of both patients cannot be attributed to the contributions to the development and success of brain tumor
implanted wafers. 8. operations. Neurosurg Focus 2005;18:e4.
Alexiou GA, Goussia A, Voulgaris S, Fotopoulos AD, Fotakopoulos G,
Ntoulia A, Zikou A, Tsekeris P, Argyropoulou MI, Kyritsis AP.
In conclusion, the role of infection provides a rationale Prognostic significance of MRP5 immunohistochemical expression
for further research in cancer treatment. Certainly, in glioblastoma. Cancer Chemother Pharmacol 2012;69:1387‑91.
there is a need for larger studies that may provide more 9. Bohman LE, Gallardo J, Hankinson TC, Waziri AE, Mandigo CE,
McKhann GM 2nd, Sisti MB, Canoll P, Bruce JN. The survival impact
accurate answers. This may also lead to a subgroup of postoperative infection in patients with glioblastoma multiforme.
analysis that would better define if patients survival is Neurosurgery 2009;64:828‑34.
influenced by bacterial strain, location of the infection 10. Löhr M, Molcanyi M, Poggenborg J, Spuentrup E, Runge M, Röhn G,
or time to infection. Hartig W, Hescheler J, Hampl JA. Intracerebral administration of
heat‑inactivated Staphylococcus epidermidis enhances oncolysis
and prolongs survival in a 9L orthotopic gliosarcoma model. Cell
REFERENCES Physiol Biochem 2013;31:614‑24.
11. Decker WK, Safdar A. Bioimmunoadjuvants for the treatment of
1. Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G, neoplastic and infectious disease: coley’s legacy revisited. Cytokine
Tsavachidis S, Liang FW, Gilbert M, Aldape K, Armstrong T, Growth Factor Rev 2009;20:271‑81.
Houlston R, Hosking F, Robertson L, Xiao Y, Wiencke J, Wrensch M, 12. Tanaka R, Sekiguchi K, Suzuki Y, Sobue H, Ueki K. Preliminary
Andersson U, Melin BS, Bondy M. Polymorphisms of LIG4, evaluation of intratumoral injection of a Streptococcus pyrogenes
BTBD2, HMGA2, and RTEL1 genes involved in the double‑strand preparation in patients with malignant brain tumors. Cancer
break repair pathway predict glioblastoma survival. J Clin Oncol 1980;46:1688‑94.
2010;28:2467‑74. 13. Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley
2. Nuño M, Birch K, Mukherjee D, Sarmiento JM, Black KL, Patil CG. and tumour regression: a place in history or in the future. Postgrad
Survival and prognostic factors of anaplastic gliomas. Neurosurgery Med J 2003;79:672‑80.
2013;73:458‑65. 14. Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A. Post operative
3. De Bonis P, Albanese A, Lofrese G, de Waure C, Mangiola A, infection and increased survival in osteosarcoma patients: are they
Pettorini BL, Pompucci A, Balducci M, Fiorentino A, Lauriola L, associated? Ann Surg Oncol 2007;14:2887‑95.
Anile C, Maira G. Postoperative infection may influence survival 15. Ruckdeschel JC, Codish SD, Stranahan A, McKneally MF. Postoperative
in patients with glioblastoma: simply a myth? Neurosurgery empyema improves survival in lung cancer. Documentation and
2011;69:864‑8. analysis of a natural experiment. N Engl J Med 1972;287:1013‑7.
4. Bowles AP Jr, Perkins E. Long‑term remission of malignant 16. Bregy A, Shah AH, Diaz MV, Pierce HE, Ames PL, Diaz D,
brain tumors after intracranial infection: a report of four cases. Komotar RJ. The role of Gliadel wafers in the treatment of high‑grade
Neurosurgery 1999;44:636‑42. gliomas. Expert Rev Anticancer Ther 2013;13:1453‑61.
5. Cairncross JG, Wang M, Jenkins RB, Shaw EG, Giannini C,
Brachman DG, Buckner JC, Fink KL, Souhami L, Laperriere NJ,
Huse JT, Mehta MP, Curran WJ, Jr. Benefit from procarbazine, Cite this article as: Alexiou GA, Kallinteri A, Michos E, Zagorianakou P,
lomustine, and vincristine in oligodendroglial tumors is associated Priavali E, Pachatouridis D, Levidiotou S, Voulgaris S. The influence of
with mutation of IDH. J Clin Oncol 2014;32:783‑90. postoperative infection in survival of patients with high-grade gliomas.
6. Panageas KS, Reiner AS, Iwamoto FM, Cloughesy TF, Aldape KD, Neuroimmunol Neuroinflammation 2015;2(1):18-20.
Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Source of Support: Nil. Conflict of Interest: No.
Ashby LS, Cairncross JG, Roldan Urgoiti GB, Wen PY, Ligon KL, Received: 19-08-2014; Accepted: 01-09-2014
20 Neuroimmunol Neuroinflammation | Volume 2 | Issue 1 | January 15, 2015